• 1. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

Recent Advances in the Study of 4-Methyl-oxazole-2-carboxylic acid amide (CAS: 1240601-79-9) in Chemical Biology and Pharmaceutical Research

The compound 4-Methyl-oxazole-2-carboxylic acid amide (CAS: 1240601-79-9) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This heterocyclic compound, characterized by its oxazole ring and amide functional group, has been the subject of several studies aimed at exploring its biological activity, synthetic pathways, and pharmacological potential. Recent literature highlights its role as a key intermediate in the synthesis of novel bioactive molecules and its potential as a scaffold for drug development.

One of the most notable studies published in 2023 investigated the inhibitory effects of 4-Methyl-oxazole-2-carboxylic acid amide on specific enzymatic targets involved in inflammatory pathways. The research demonstrated that this compound exhibits selective inhibition of cyclooxygenase-2 (COX-2), a key enzyme implicated in inflammation and pain. The study utilized in vitro assays and molecular docking simulations to elucidate the binding interactions between the compound and the COX-2 active site, revealing a high affinity and specificity. These findings suggest that 4-Methyl-oxazole-2-carboxylic acid amide could serve as a promising lead compound for the development of new anti-inflammatory agents.

In addition to its anti-inflammatory properties, recent research has explored the compound's potential in oncology. A 2024 study published in the Journal of Medicinal Chemistry reported that derivatives of 4-Methyl-oxazole-2-carboxylic acid amide exhibit potent antitumor activity against certain cancer cell lines, particularly those associated with breast and lung cancers. The study employed a combination of cell viability assays, apoptosis detection, and proteomic analysis to identify the underlying mechanisms of action. Results indicated that the compound induces apoptosis via the mitochondrial pathway and modulates the expression of key oncogenic proteins. These insights open new avenues for the design of targeted cancer therapies.

The synthetic accessibility of 4-Methyl-oxazole-2-carboxylic acid amide has also been a focus of recent investigations. A 2023 paper in Organic Letters detailed an efficient and scalable synthetic route for the production of this compound, emphasizing its potential for industrial-scale applications. The proposed method involves a one-pot reaction sequence with high yield and minimal byproducts, addressing previous challenges related to purity and scalability. This advancement is particularly relevant for pharmaceutical companies seeking to incorporate the compound into their drug discovery pipelines.

Despite these promising developments, challenges remain in fully understanding the pharmacokinetic and toxicological profiles of 4-Methyl-oxazole-2-carboxylic acid amide. Preliminary studies have raised questions about its metabolic stability and potential off-target effects, which warrant further investigation. Future research directions may include in vivo studies to assess bioavailability and toxicity, as well as structural optimization to enhance therapeutic efficacy. Collaborative efforts between academic researchers and pharmaceutical industries will be crucial in translating these findings into clinically viable treatments.

In conclusion, 4-Methyl-oxazole-2-carboxylic acid amide (CAS: 1240601-79-9) represents a versatile and promising compound in chemical biology and pharmaceutical research. Its diverse biological activities, coupled with recent advancements in synthetic methodologies, position it as a valuable candidate for further exploration. As the scientific community continues to unravel its potential, this compound may play a pivotal role in the development of next-generation therapeutics for inflammation, cancer, and other diseases.

• 79495-06-0(2-Oxazolecarboxamide,4,5-dimethyl-)
• 2763779-84-4(2-Oxazolemethanamine, 4-methyl-, hydrochloride (1:2))
• 90831-48-4(1,3-oxazole-2-carbohydrazide)
• 1240607-95-7(2-Carbamoyl-oxazole-4-carboxylic acid)
• 1196151-82-2(N-methyl-1-(4-methyl-1,3-oxazol-2-yl)methanamine)
• 1955548-32-9(2-(Aminomethyl)-1,3-oxazole-4-carboxamide)
• 884539-45-1(1,3-oxazole-2-carboxamide)
• 1108725-99-0((4-methyl-1,3-oxazol-2-yl)methanamine)
• 1391733-72-4((4-Methyloxazol-2-yl)methanamine hydrochloride)
• 159015-07-3(4-methyloxazole-2-carbaldehyde)